Keywords: janssen-kyowa, launches, itrazole, japan, launched, its, oral
JANSSEN-KYOWA LAUNCHES ITRAZOLE IN JAPAN
Article | 20 September 1993
Janssen-Kyowa has launched its oral antifungal product, Itrizole Cap 50 (itraconazole), onto the 30 billion yen ($283 million) Japanese market. The broad-spectrum product ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
